Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype

Cancer Biology and Therapy

Volumn 16, Issue 11, 2015, Pages 1671-1681

  Shah, Sanket H ^a   Miller, Philip ^c   Garcia Contreras, Marta ^b   Ao, Zheng ^a   Machlin, Leah ^c   Issa, Emilio ^d   El Ashry, Dorraya ^b,c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MIAMI   (United States)

^d Department of Biology   (United States)

Author keywords

CAFs; Estrogen receptor; exosomes; MAPK; microRNA; TME

Indexed keywords

ESTROGEN RECEPTOR; MICRORNA 221; MICRORNA 222; MITOGEN ACTIVATED PROTEIN KINASE; CONDITIONED MEDIUM; MICRORNA; MIRN221 MICRORNA, HUMAN; MIRN222 MICRORNA, HUMAN;

ARTICLE; BREAST CANCER; CANCER ASSOCIATED FIBROBLAST; CANCER CELL; CELL INFILTRATION; CONTROLLED STUDY; CULTURE MEDIUM; EXOSOME; FIBROBLAST; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; PROTEIN EXPRESSION; STROMA CELL; TRANSMISSION ELECTRON MICROSCOPY; TUMOR MICROENVIRONMENT; BREAST TUMOR; CONDITIONED MEDIUM; ENZYMOLOGY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETICS; MCF-7 CELL LINE; METABOLISM; PARACRINE SIGNALING; PATHOLOGY; PHYSIOLOGY; RNA INTERFERENCE;

BREAST NEOPLASMS; CULTURE MEDIA, CONDITIONED; EXOSOMES; FEMALE; FIBROBLASTS; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MCF-7 CELLS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASES; PARACRINE COMMUNICATION; PHENOTYPE; RECEPTORS, ESTROGEN; RNA INTERFERENCE; TUMOR MICROENVIRONMENT;

EID: 84948585653     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2015.1071742     Document Type: Article

References (84)

1. T.D.Tlsty. Stromal cells can contribute oncogenic signals. Semin Cancer Biol 2001; 11:97-104; PMID:11322829; http://dx.doi.org/10.1006/scbi.2000.0361
2. M.Allinen, R.Beroukhim, L.Cai, C.Brennan, J.Lahti-Domenici, H.Huang, D.Porter, M.Hu, L.Chin, A.Richardson, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer cell 2004; 6:17-32.
3. D.X.Nguyen, P.D.Bos, J.Massague. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9:274-U65; PMID:19308067; http://dx.doi.org/10.1038/nrc2622
4. D.Hanahan, R.A.Weinberg. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j.cell.2011.02.013
5. R.Kalluri, M.Zeisberg. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392-401; PMID:16572188; http://dx.doi.org/10.1038/nrc1877
6. J.Folkman. Tumor angiogenesis: therapeutic implications. N Eng J Med 1971; 285:1182-6; PMID:4938153; http://dx.doi.org/10.1056/NEJM197108122850711
7. T.D.Tlsty, P.W.Hein. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr Opin Genet Dev 2001; 11:54-9; PMID:11163151; http://dx.doi.org/10.1016/S0959-437X(00)00156-8
8. L.Ronnov-Jessen, O.W.Petersen, M.J.Bissell. Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev 1996; 76:69-125; PMID:8592733
9. P.Schedin, A.Elias. Multistep tumorigenesis and the microenvironment. Breast Cancer Res 2004; 6:93-101; PMID:14979914; http://dx.doi.org/10.1186/bcr772
10. M.P.Shekhar, R.Pauley, G.Heppner. Host microenvironment in breast cancer development: extracellular matrix-stromal cell contribution to neoplastic phenotype of epithelial cells in the breast. Breast Cancer Res 2003; 5:130-5; PMID:12793893; http://dx.doi.org/10.1186/bcr580
11. L.C.van Kempen, D.J.Ruiter, G.N.van Muijen, L.M.Coussens. The tumor microenvironment: a critical determinant of neoplastic evolution. Eur J Cell Biol 2003; 82:539-48; PMID:14703010; http://dx.doi.org/10.1078/0171-9335-00346
12. A.Orimo, R.A.Weinberg. Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 2006; 5:1597-601; PMID:16880743; http://dx.doi.org/10.4161/cc.5.15.3112
13. A.P.Sappino, O.Skalli, B.Jackson, W.Schurch, G.Gabbiani. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues. Int J Cancer 1988; 41:707-12; PMID:2835323; http://dx.doi.org/10.1002/ijc.2910410512
14. M.Augsten. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol 2014; 4:62; PMID:24734219; http://dx.doi.org/10.3389/fonc.2014.00062
15. R.Straussman, T.Morikawa, K.Shee, M.Barzily-Rokni, Z.R.Qian, J.Du, A.Davis, M.M.Mongare, J.Gould, D.T.Frederick, et al. Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion. Nature 2012; 487:500-4; PMID:22763439; http://dx.doi.org/10.1038/nature11183
16. M.P.Shekhar, S.Santner, K.A.Carolin, L.Tait. Direct involvement of breast tumor fibroblasts in the modulation of tamoxifen sensitivity. Am J Pathol 2007; 170:1546-60; PMID:17456761; http://dx.doi.org/10.2353/ajpath.2007.061004
17. M.Q.Gao, B.G.Kim, S.Kang, Y.P.Choi, H.Park, K.S.Kang, N.H.Cho. Stromal fibroblasts from the interface zone of human breast carcinomas induce an epithelial-mesenchymal transition-like state in breast cancer cells in vitro. J Cell Sci 2010; 123:3507-14; PMID:20841377; http://dx.doi.org/10.1242/jcs.072900
18. M.M.Mueller, N.E.Fusenig. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004; 4:839-49; PMID:15516957; http://dx.doi.org/10.1038/nrc1477
19. A.Orimo, P.B.Gupta, D.C.Sgroi, F.Arenzana-Seisdedos, T.Delaunay, R.Naeem, V.J.Carey, A.L.Richardson, R.A.Weinberg. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005; 121:335-48; PMID:15882617; http://dx.doi.org/10.1016/j.cell.2005.02.034
20. N.A.Bhowmick, E.G.Neilson, H.L.Moses. Stromal fibroblasts in cancer initiation and progression. Nature 2004; 432:332-7; PMID:15549095; http://dx.doi.org/10.1038/nature03096
21. S.Giulianelli, J.P.Cerliani, C.A.Lamb, V.T.Fabris, M.C.Bottino, M.A.Gorostiaga, V.Novaro, A.Góngora, A.Baldi, A.Molinolo, et al. Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis. Int J Cancer 2008; 123:2518-31; PMID:18767044; http://dx.doi.org/10.1002/ijc.23802
22. E.Giannoni, F.Bianchini, L.Masieri, S.Serni, E.Torre, L.Calorini, P.Chiarugi. Reciprocal activation of prostate cancer cells and cancer-associated fibroblasts stimulates epithelial-mesenchymal transition and cancer stemness. Cancer Res 2010; 70:6945-56; PMID:20699369; http://dx.doi.org/10.1158/0008-5472.CAN-10-0785
23. K.D.Grugan, C.G.Miller, Y.Yao, C.Z.Michaylira, S.Ohashi, A.J.Klein-Szanto, J.A.Diehl, M.Herlyn, M.Han, H.Nakagawa, et al. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci U S A 2010; 107:11026-31; PMID:20534479; http://dx.doi.org/10.1073/pnas.0914295107
24. S.W.Tyan, W.H.Kuo, C.K.Huang, C.C.Pan, J.Y.Shew, K.J.Chang, E.Y.Lee, W.H.Lee. Breast cancer cells induce cancer-associated fibroblasts to secrete hepatocyte growth factor to enhance breast tumorigenesis. PloS One 2011; 6:e15313; PMID:21249190; http://dx.doi.org/10.1371/journal.pone.0015313
25. W.G.Stetler-Stevenson, S.Aznavoorian, L.A.Liotta. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993; 9:541-73; PMID:8280471; http://dx.doi.org/10.1146/annurev.cb.09.110193.002545
26. M.D.Sternlicht, A.Lochter, C.J.Sympson, B.Huey, J.P.Rougier, J.W.Gray, D.Pinkel, M.J.Bissell, Z.Werb. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999; 98:137-46; PMID:10428026; http://dx.doi.org/10.1016/S0092-8674(00)81009-0
27. A.W.Studebaker, G.Storci, J.L.Werbeck, P.Sansone, A.K.Sasser, S.Tavolari, T.Huang, M.W.Chan, F.C.Marini, T.J.Rosol, et al. Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Res 2008; 68:9087-95; PMID:18974155; http://dx.doi.org/10.1158/0008-5472.CAN-08-0400
28. M.A.Bogoyevitch, P.E.Glennon, M.B.Andersson, A.Clerk, A.Lazou, C.J.Marshall, P.J.Parker, P.H.Sugden. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J Biol Chem 1994; 269:1110-9; PMID:7507104
29. B.A.Teicher, S.P.Fricker. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010; 16:2927-31; PMID:20484021; http://dx.doi.org/10.1158/1078-0432.CCR-09-2329
30. D.Javelaud, A.Mauviel. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesis. Oncogene 2005; 24:5742-50; PMID:16123807; http://dx.doi.org/10.1038/sj.onc.1208928
31. R.Derynck, Y.E.Zhang. Smad-dependent and Smad-independent pathways in TGF-β family signalling. Nature 2003; 425:577-84; PMID:14534577; http://dx.doi.org/10.1038/nature02006
32. Q.Qiu, M.Yang, B.K.Tsang, A.Gruslin. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways. Reproduction 2004; 128:355-63; PMID:15333786; http://dx.doi.org/10.1530/rep.1.00234
33. A.Ogata, D.Chauhan, G.Teoh, S.P.Treon, M.Urashima, R.L.Schlossman, K.C.Anderson. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade. J Immunol 1997; 159:2212-21.
34. K.Drews-Elger, J.A.Brinkman, P.Miller, S.H.Shah, J.C.Harrell, T.G.da Silva, Z.Ao, A.Schlater, D.J.Azzam, K.Diehl, et al. Primary breast tumor-derived cellular models: characterization of tumorigenic, metastatic, and cancer-associated fibroblasts in dissociated tumor (DT) cultures. Breast Cancer Res Treat 2014; 144:503-17; PMID:24567196; http://dx.doi.org/10.1007/s10549-014-2887-9
35. C.J.Creighton, A.M.Hilger, S.Murthy, J.M.Rae, A.M.Chinnaiyan, D.El-Ashry. Activation of mitogen-activated protein kinase in estrogen receptor α-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor α-negative human breast tumors. Cancer Res 2006; 66:3903-11; PMID:16585219; http://dx.doi.org/10.1158/0008-5472.CAN-05-4363
36. J.Bayliss, A.Hilger, P.Vishnu, K.Diehl, D.El-Ashry. Reversal of the estrogen receptor negative phenotype in breast cancer and restoration of antiestrogen response. Clin Cancer Res 2007; 13:7029-36; PMID:18056179; http://dx.doi.org/10.1158/1078-0432.CCR-07-0587
37. A.S.Oh, L.A.Lorant, J.N.Holloway, D.L.Miller, F.G.Kern, D.El-Ashry. Hyperactivation of MAPK induces loss of ERalpha expression in breast cancer cells. Mol Endocrinol 2001; 15:1344-59; PMID:11463858
38. P.Miller, J.Clarke, T.Koru-Sengul, J.Brinkman, D.El-Ashry. A novel MAPK-microRNA signature is predictive of hormone-therapy resistance and poor outcome in ER-positive breast cancer. Clin Cancer Res 2015 Jan 15;21(2):373-85.
39. D.P.Pandey, D.Picard. miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor α mRNA. Mol Cell Biol 2009; 29:3783-90; PMID:19414598; http://dx.doi.org/10.1128/MCB.01875-08
40. J.Xiong, D.Yu, N.Wei, H.Fu, T.Cai, Y.Huang, C.Wu, X.Zheng, Q.Du, D.Lin, et al. An estrogen receptor α suppressor, microRNA-22, is downregulated in estrogen receptor α-positive human breast cancer cell lines and clinical samples. FEBS J 2010; 277:1684-94; PMID:20180843; http://dx.doi.org/10.1111/j.1742-4658.2010.07594.x
41. D.R.Cochrane, D.M.Cittelly, E.N.Howe, N.S.Spoelstra, E.L.McKinsey, K.LaPara, A.Elias, D.Yee, J.K.Richer. MicroRNAs link estrogen receptor α status and Dicer levels in breast cancer. Horm Cancer 2010; 1:306-19; PMID:21761362; http://dx.doi.org/10.1007/s12672-010-0043-5
42. J.J.Zhao, J.Lin, H.Yang, W.Kong, L.He, X.Ma, D.Coppola, J.Q.Cheng. MicroRNA-221/222 negatively regulates estrogen receptor α and is associated with tamoxifen resistance in breast cancer. J Biol Chem 2008; 283:31079-86; PMID:18790736; http://dx.doi.org/10.1074/jbc.M806041200
43. Y.Wei, X.Lai, S.Yu, S.Chen, Y.Ma, Y.Zhang, H.Li, X.Zhu, L.Yao, J.Zhang. Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat 2014; 147:423-31; PMID:25007959; http://dx.doi.org/10.1007/s10549-014-3037-0
44. R.Schickel, B.Boyerinas, S.M.Park, M.E.Peter. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene 2008; 27:5959-74; PMID:18836476; http://dx.doi.org/10.1038/onc.2008.274
45. F.J.Kohlhapp, A.K.Mitra, E.Lengyel, M.E.Peter. MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment. Oncogene 2015; ePub ahead of print; PMID:25867073
46. G.A.Calin, C.G.Liu, C.Sevignani, M.Ferracin, N.Felli, C.D.Dumitru, M.Shimizu, A.Cimmino, S.Zupo, M.Dono, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004; 101:11755-60; PMID:15284443; http://dx.doi.org/10.1073/pnas.0404432101
47. J.Lu, G.Getz, E.A.Miska, E.Alvarez-Saavedra, J.Lamb, D.Peck, A.Sweet-Cordero, B.L.Ebert, R.H.Mak, A.A.Ferrando, et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8; PMID:15944708; http://dx.doi.org/10.1038/nature03702
48. M.V.Iorio, M.Ferracin, C.G.Liu, A.Veronese, R.Spizzo, S.Sabbioni, E.Magri, M.Pedriali, M.Fabbri, M.Campiglio, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65:7065-70; PMID:16103053; http://dx.doi.org/10.1158/0008-5472.CAN-05-1783
49. A.J.Lowery, N.Miller, A.Devaney, R.E.McNeill, P.A.Davoren, C.Lemetre, V.Benes, S.Schmidt, J.Blake, G.Ball, et al. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer. Breast Cancer Res 2009; 11:R27; PMID:19432961; http://dx.doi.org/10.1186/bcr2257
50. M.D.Mattie, C.C.Benz, J.Bowers, K.Sensinger, L.Wong, G.K.Scott, V.Fedele, D.Ginzinger, R.Getts, C.Haqq. Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 2006; 5:24; PMID:16784538; http://dx.doi.org/10.1186/1476-4598-5-24
51. E.Enerly, I.Steinfeld, K.Kleivi, S.K.Leivonen, M.R.Aure, H.G.Russnes, J.A.Rønneberg, H.Johnsen, R.Navon, E.Rødland, et al. miRNA-mRNA integrated analysis reveals roles for miRNAs in primary breast tumors. PloS One 2011; 6:e16915; PMID:21364938; http://dx.doi.org/10.1371/journal.pone.0016915
52. C.Blenkiron, L.D.Goldstein, N.P.Thorne, I.Spiteri, S.F.Chin, M.J.Dunning, N.L.Barbosa-Morais, A.E.Teschendorff, A.R.Green, I.O.Ellis, et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol 2007; 8:R214; PMID:17922911; http://dx.doi.org/10.1186/gb-2007-8-10-r214
53. D.de Ridder, C.E.van der Linden, T.Schonewille, W.A.Dik, M.J.Reinders, J.J.van Dongen, F.J.Staal. Purity for clarity: the need for purification of tumor cells in DNA microarray studies. Leukemia 2005; 19:618-27; PMID:15744349
54. K.Yoshihara, M.Shahmoradgoli, E.Martinez, R.Vegesna, H.Kim, W.Torres-Garcia, V.Treviño, H.Shen, P.W.Laird, D.A.Levine, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013; 4:2612; PMID:24113773; http://dx.doi.org/10.1038/ncomms3612
55. S.L.Carter, K.Cibulskis, E.Helman, A.McKenna, H.Shen, T.Zack, P.W.Laird, R.C.Onofrio, W.Winckler, B.A.Weir, et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012; 30:413-21; PMID:22544022; http://dx.doi.org/10.1038/nbt.2203
56. P.Van Loo, S.H.Nordgard, O.C.Lingjaerde, H.G.Russnes, I.H.Rye, W.Sun, V.J.Weigman, P.Marynen, A.Zetterberg, B.Naume, et al. Allele-specific copy number analysis of tumors. Proc Natl Acad Sci U S A 2010; 107:16910-5; PMID:20837533; http://dx.doi.org/10.1073/pnas.1009843107
57. J.An, A.Enomoto, L.Weng, T.Kato, A.Iwakoshi, K.Ushida, K.Maeda, M.Ishida-Takagishi, G.Ishii, S.Ming, et al. Significance of cancer-associated fibroblasts in the regulation of gene expression in the leading cells of invasive lung cancer. J Cancer Res Clin Oncol 2013; 139:379-88; PMID:23108890; http://dx.doi.org/10.1007/s00432-012-1328-6
58. D.El-Ashry, D.L.Miller, S.Kharbanda, M.E.Lippman, F.G.Kern. Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis. Oncogene 1997; 15:423-35; PMID:9242379; http://dx.doi.org/10.1038/sj.onc.1201198
59. V.Luga, L.Zhang, A.M.Viloria-Petit, A.A.Ogunjimi, M.R.Inanlou, E.Chiu, M.Buchanan, A.N.Hosein, M.Basik, J.L.Wrana. Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell 2012; 151:1542-56; PMID:23260141; http://dx.doi.org/10.1016/j.cell.2012.11.024
60. X.Chen, H.Liang, J.Zhang, K.Zen, C.Y.Zhang. Secreted microRNAs: a new form of intercellular communication. Trends Cell Biol 2012; 22:125-32; PMID:22260888; http://dx.doi.org/10.1016/j.tcb.2011.12.001
61. C.Thery, L.Zitvogel, S.Amigorena. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002; 2:569-79; PMID:12154376
62. R.A.Boon, K.C.Vickers. Intercellular transport of microRNAs. Arterioscler Thromb Vasc Biol 2013; 33:186-92; PMID:23325475; http://dx.doi.org/10.1161/ATVBAHA.112.300139
63. J.Lotvall, H.Valadi. Cell to cell signalling via exosomes through esRNA. Cell Adh Migr 2007; 1:156-8; PMID:19262134; http://dx.doi.org/10.4161/cam.1.3.5114
64. H.Valadi, K.Ekstrom, A.Bossios, M.Sjostrand, J.J.Lee, J.O.Lotvall. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9:654-9; PMID:17486113; http://dx.doi.org/10.1038/ncb1596
65. T.Umezu, K.Ohyashiki, M.Kuroda, J.H.Ohyashiki. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene 2013; 32:2747-55; PMID:22797057; http://dx.doi.org/10.1038/onc.2012.295
66. A.Bobrie, M.Colombo, G.Raposo, C.Thery. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic 2011; 12:1659-68; PMID:21645191; http://dx.doi.org/10.1111/j.1600-0854.2011.01225.x
67. D.M.Pegtel, M.D.van de Garde, J.M.Middeldorp. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta 2011; 1809:715-21; PMID:21855666; http://dx.doi.org/10.1016/j.bbagrm.2011.08.002
68. M.Yang, J.Chen, F.Su, B.Yu, F.Su, L.Lin, Y.Liu, J.D.Huang, E.Song. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer 2011; 10:117; PMID:21939504; http://dx.doi.org/10.1186/1476-4598-10-117
69. Y.Zhang, D.Liu, X.Chen, J.Li, L.Li, Z.Bian, F.Sun, J.Lu, Y.Yin, X.Cai, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 2010; 39:133-44; PMID:20603081; http://dx.doi.org/10.1016/j.molcel.2010.06.010
70. F.Collino, M.C.Deregibus, S.Bruno, L.Sterpone, G.Aghemo, L.Viltono, C.Tetta, G.Camussi. Microvesicles derived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of miRNAs. PloS One 2010; 5:e11803; PMID:20668554; http://dx.doi.org/10.1371/journal.pone.0011803
71. R.Ogawa, C.Tanaka, M.Sato, H.Nagasaki, K.Sugimura, K.Okumura, Y.Nakagawa, N.Aoki. Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun 2010; 398:723-9; PMID:20621060; http://dx.doi.org/10.1016/j.bbrc.2010.07.008
72. G.Muller, M.Schneider, G.Biemer-Daub, S.Wied. Microvesicles released from rat adipocytes and harboring glycosylphosphatidylinositol-anchored proteins transfer RNA stimulating lipid synthesis. Cell Signal 2011; 23:1207-23; PMID:21435393; http://dx.doi.org/10.1016/j.cellsig.2011.03.013
73. V.Muralidharan-Chari, J.W.Clancy, A.Sedgwick, C.D'Souza-Schorey. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123:1603-11; PMID:20445011; http://dx.doi.org/10.1242/jcs.064386
74. C.Kahlert, R.Kalluri. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med 2013; 91:431-7; PMID:23519402; http://dx.doi.org/10.1007/s00109-013-1020-6
75. J.Tchou, A.V.Kossenkov, L.Chang, C.Satija, M.Herlyn, L.C.Showe, E.Puré. Human breast cancer associated fibroblasts exhibit subtype specific gene expression profiles. BMC Med Genom 2012; 5:39; PMID:22954256; http://dx.doi.org/10.1186/1755-8794-5-39
76. S.Y.Park, H.M.Kim, J.S.Koo. Differential expression of cancer-associated fibroblast-related proteins according to molecular subtype and stromal histology in breast cancer. Breast Cancer Res Treat 2015; 149:727-41; PMID:25667103; http://dx.doi.org/10.1007/s10549-015-3291-9
77. J.Skog, T.Wurdinger, S.van Rijn, D.H.Meijer, L.Gainche, M.Sena-Esteves, W.T.CurryJr, B.S.Carter, A.M.Krichevsky, X.O.Breakefield. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-6; PMID:19011622; http://dx.doi.org/10.1038/ncb1800
78. D.J.Gibbings, C.Ciaudo, M.Erhardt, O.Voinnet. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat Cell Biol 2009; 11:1143-9; PMID:19684575; http://dx.doi.org/10.1038/ncb1929
79. J.Guduric-Fuchs, A.O'Connor, B.Camp, C.L.O'Neill, R.J.Medina, D.A.Simpson. Selective extracellular vesicle-mediated export of an overlapping set of microRNAs from multiple cell types. BMC Genom 2012; 13:357; PMID:22849433; http://dx.doi.org/10.1186/1471-2164-13-357
80. E.N.Nolte-'t Hoen, H.P.Buermans, M.Waasdorp, W.Stoorvogel, M.H.Wauben, P.A.t Hoen. Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions. Nucleic Acids Res 2012; 40:9272-85; PMID:22821563; http://dx.doi.org/10.1093/nar/gks658
81. M.Simons, G.Raposo. Exosomes–vesicular carriers for intercellular communication. Curr Opin Cell Biol 2009; 21:575-81; PMID:19442504; http://dx.doi.org/10.1016/j.ceb.2009.03.007
82. M.L.Squadrito, C.Baer, F.Burdet, C.Maderna, G.D.Gilfillan, R.Lyle, M.Ibberson, M.De Palma. Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells. Cell Rep 2014; 8:1432-46; PMID:25159140; http://dx.doi.org/10.1016/j.celrep.2014.07.035
83. F.Stossi, Z.Madak-Erdogan, B.S.Katzenellenbogen. Macrophage-elicited loss of estrogen receptor-α in breast cancer cells via involvement of MAPK and c-Jun at the ESR1 genomic locus. Oncogene 2012; 31:1825-34; PMID:21860415; http://dx.doi.org/10.1038/onc.2011.370
84. U.D.Bayraktar, T.K.Kim, K.Drews-Elger, C.Benjamin, D.El-Ashry, E.Wieder, K.V.Komanduri. Simultaneous measurement of ERalpha, HER2, and phosphoERK1/2 in breast cancer cell lines by flow cytometry. Breast Cancer Res Treat 2011; 129:623-8; PMID:21607585; http://dx.doi.org/10.1007/s10549-011-1586-z